| For: | Serra G, Demontis F, Serra F, De Chiara L, Spoto A, Girardi P, Vidotto G, Serra G. Memantine: New prospective in bipolar disorder treatment. World J Psychiatr 2014; 4(4): 80-90 [PMID: 25540723 DOI: 10.5498/wjp.v4.i4.80] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v4/i4/80.htm |
| Number | Citing Articles |
| 1 |
Giuseppe Quaranta, Angelo Giovanni Icro Maremmani, Giulio Perugi. Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner Syndrome. Case Reports in Psychiatry 2015; 2015 doi: 10.1155/2015/273192
|
| 2 |
Xiao-Ting Huang, Shao-Jie Yue, Chen Li, Jia Guo, Yan-Hong Huang, Jian-Zhong Han, Dan-Dan Feng, Zi-Qiang Luo. Antenatal blockade of N-methyl-D-aspartate receptors by Memantine reduces the susceptibility to diabetes induced by a high-fat diet in rats with intrauterine growth restriction†. Biology of Reproduction 2017; 96(5) doi: 10.1095/biolreprod.116.145011
|
| 3 |
Susan M. Kilonzo. The Palgrave Handbook of Religion, Health and Development in Africa. 2025; doi: 10.1007/978-3-031-62891-7_55-1
|
| 4 |
Erin T Carey, Sawsan As-Sanie. New Developments in the Pharmacotherapy of Neuropathic Chronic Pelvic Pain. Future Science OA 2016; 2(4) doi: 10.4155/fsoa-2016-0048
|
| 5 |
Ana Maria Orellana, Paula Fernanda Kinoshita, Jacqueline Alves Leite, Elisa Mitiko Kawamoto, Cristoforo Scavone. Cardiotonic Steroids as Modulators of Neuroinflammation. Frontiers in Endocrinology 2016; 7 doi: 10.3389/fendo.2016.00010
|
| 6 |
Francesca Demontis, Gino Serra. Failure of memantine to “reverse” quinpirole-induced hypomotility. World Journal of Psychiatry 2016; 6(2): 215-220 doi: 10.5498/wjp.v6.i2.215
|
| 7 |
Ana Hategan, James A. Bourgeois. Donepezil-associated manic episode with psychotic features: a case report and review of the literature. General Hospital Psychiatry 2016; 38 doi: 10.1016/j.genhosppsych.2015.09.004
|
| 8 |
Victoria Omranifard, Mohammad Javad Tarrahi, Shima Sharifi, Mojgan Karahmadi. Evaluation of the Effect of Memantine Supplementation in the Treatment of Acute Phase of Mania in Bipolar Disorder of Elderly Patients: A Double-blind Randomized Controlled Trial. Advanced Biomedical Research 2018; 7(1) doi: 10.4103/abr.abr_110_18
|
| 9 |
Mauro Giovanni Carta, Goce Kalcev, Michele Fornaro, Antonio Egidio Nardi. Novel experimental and early investigational drugs for the treatment of bipolar disorder. Expert Opinion on Investigational Drugs 2021; 30(11) doi: 10.1080/13543784.2021.2000965
|
| 10 |
Susan M. Kilonzo. The Palgrave Handbook of Religion, Health and Development in Africa. 2026; doi: 10.1007/978-3-032-05464-7_55
|
| 11 |
Chiara Montemitro, Alexandra Angebrandt, Tzu-Yun Wang, Mauro Pettorruso, Osama A. Abulseoud. Mechanistic insights into the efficacy of memantine in treating certain drug addictions. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2021; 111 doi: 10.1016/j.pnpbp.2021.110409
|
| 12 |
Saptapadi Saha, Arun Baidya, Shuvam Sar, Tanmoy Banerjee, Ankit Kumar, Axata Lama, Rituparna Chaki, Amit Halder, Nilanjan Ghosh. Drug Repurposing: Exploring Newer Therapeutic Potentials. 2026; doi: 10.1007/978-981-95-4522-3_12
|
| 13 |
Kate M. Chitty, Jim Lagopoulos, Ian B. Hickie, Daniel F. Hermens. Alcohol use in bipolar disorder: A neurobiological model to help predict susceptibility, select treatments and attenuate cortical insult. Neuroscience & Biobehavioral Reviews 2015; 56 doi: 10.1016/j.neubiorev.2015.07.004
|
| 14 |
Gustavo de Souza Pessôa, Jemmyson Romário de Jesus, Tiago Santana Balbuena, Marco Aurélio Zezzi Arruda. Metallomics‐based platforms for comparing the human blood serum profiles between bipolar disorder and schizophrenia patients. Rapid Communications in Mass Spectrometry 2020; 34(S3) doi: 10.1002/rcm.8698
|
| 15 |
Pernille Bøttger, Simon Glerup, Bodil Gesslein, Nina B. Illarionova, Toke J. Isaksen, Anders Heuck, Bettina H. Clausen, Ernst-Martin Füchtbauer, Jan B. Gramsbergen, Eli Gunnarson, Anita Aperia, Martin Lauritzen, Kate L. Lambertsen, Poul Nissen, Karin Lykke-Hartmann. Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model. Scientific Reports 2016; 6(1) doi: 10.1038/srep22047
|
| 16 |
Fatemeh Forouzanfar, Amir Mahmoud Ahmadzadeh, Ali Mohammad Pourbagher-Shahri, Ali Gorji. Significance of NMDA receptor-targeting compounds in neuropsychological disorders: An in-depth review. European Journal of Pharmacology 2025; 999 doi: 10.1016/j.ejphar.2025.177690
|
| 17 |
Erin T. Carey, Sara R. Till, Sawsan As-Sanie. Pharmacological Management of Chronic Pelvic Pain in Women. Drugs 2017; 77(3) doi: 10.1007/s40265-016-0687-8
|
| 18 |
An excessive increase in glutamate contributes to glucose-toxicity in β-cells via activation of pancreatic NMDA receptors in rodent diabetes. Scientific Reports 2017; 7(1) doi: 10.1038/srep44120
|
| 19 |
Renata Kloc, Ewa M. Urbanska. Memantine and the Kynurenine Pathway in the Brain: Selective Targeting of Kynurenic Acid in the Rat Cerebral Cortex. Cells 2024; 13(17) doi: 10.3390/cells13171424
|
| 20 |
Hiroki Kawai, Manabu Takaki, Shinji Sakamoto, Takashi Shibata, Ayaka Tsuchida, Bunta Yoshimura, Yuji Yada, Namiko Matsumoto, Kota Sato, Koji Abe, Yuko Okahisa, Yoshiki Kishi, Soshi Takao, Ko Tsutsui, Takashi Kanbayashi, Keiko Tanaka, Norihito Yamada. Anti-NMDA-receptor antibody in initial diagnosis of mood disorder. European Neuropsychopharmacology 2019; 29(9) doi: 10.1016/j.euroneuro.2019.07.137
|
| 21 |
Ignazia Mocci, Maria Antonietta Casu, Valeria Sogos, Anna Liscia, Rossella Angius, Francesca Cadeddu, Maura Fanti, Patrizia Muroni, Giuseppe Talani, Andrea Diana, Maria Collu, Maria Dolores Setzu. Effects of memantine on mania‐like phenotypes exhibited by Drosophila Shaker mutants. CNS Neuroscience & Therapeutics 2023; 29(7) doi: 10.1111/cns.14145
|
| 22 |
Fei Wang, Zhirong Zou, Yi Gong, Dong Yuan, Xun Chen, Tao Sun. Regulation of Human Brain Microvascular Endothelial Cell Adhesion and Barrier Functions by Memantine. Journal of Molecular Neuroscience 2017; 62(1) doi: 10.1007/s12031-017-0917-x
|
| 23 |
Vahid Shafiei-Irannejad, Samin Abbaszadeh, Paul M.L. Janssen, Hamid Soraya. Memantine and its benefits for cancer, cardiovascular and neurological disorders. European Journal of Pharmacology 2021; 910 doi: 10.1016/j.ejphar.2021.174455
|
| 24 |
Jin-Chen Yang, Annette Rodriguez, Ashley Royston, Yu-Qiong Niu, Merve Avar, Ryan Brill, Christa Simon, Jim Grigsby, Randi J. Hagerman, John M. Olichney. Memantine Improves Attentional Processes in Fragile X-Associated Tremor/Ataxia Syndrome: Electrophysiological Evidence from a Randomized Controlled Trial. Scientific Reports 2016; 6(1) doi: 10.1038/srep21719
|
| 25 |
Grigorios N. Karakatsoulis, Konstantinos N. Fountoulakis. Glutamate and Neuropsychiatric Disorders. 2022; doi: 10.1007/978-3-030-87480-3_8
|
| 26 |
|
| 27 |
I. S. Preobrazhenskaya. Cognitive impairment and depression. Meditsinskiy sovet = Medical Council 2023; (21) doi: 10.21518/ms2023-246
|
| 28 |
Guanglu Li, Baoquan Qu, Tao Zheng, Shaojie Duan, Lei Liu, Zunjing Liu. Role of memantine in adult migraine: a systematic review and network meta-analysis to compare memantine with existing migraine preventive medications. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1496621
|
| 29 |
Juliana C Corrêa-Velloso, Maria CB Gonçalves, Yahaira Naaldijk, Ágatha Oliveira-Giacomelli, Micheli M Pillat, Henning Ulrich. Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018; 80 doi: 10.1016/j.pnpbp.2017.04.033
|
| 30 |
Nicola Veronese, Marco Solmi, Claudio Luchini, Ru-Band Lu, Brendon Stubbs, Leonardo Zaninotto, Christoph U. Correll. Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions. Journal of Affective Disorders 2016; 197 doi: 10.1016/j.jad.2016.03.034
|